1.42
-0.01(-0.70%)
Currency In USD
Address
3222 Phoenixville Pike
Malvern, PA 19355
United States of America
Phone
610 640 4202
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
716
First IPO Date
June 28, 2018
| Name | Title | Pay | Year Born |
| Stephen J. Furlong | Senior Advisor to the Chief Executive Officer | 636,179 | 1964 |
| Keith J. Sullivan | President, Chief Executive Officer & Director | 927,610 | 1958 |
| W. Andrew Macan | EVice President, Chief Legal Officer & Corporate Secretary | 547,313 | 1973 |
| Cory S. Anderson | SVP & Chief Technology Officer | 0 | N/A |
| Jeffrey S. Jones | Senior VP & Chief of Operations | 0 | 1956 |
| Steven E. Pfanstiel | Executive VP, Treasurer & CFO | 0 | 1973 |
| William Leonard | Chief Clinic Officer | 0 | 1965 |
| Lisa Metzner-Rosas | Senior Vice President & Chief Marketing Officer | 0 | N/A |
| Sara Grubbs | Senior VP & Chief Revenue Officer | 0 | N/A |
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.